PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34428833-0	2021	Tetrahydrocurcumin Downregulates MAPKs/cPLA2 Signaling and Attenuates Platelet Thromboxane A2 Generation, Granule Secretion, and Thrombus Growth.	tetrahydrocurcumin	0-18	phospholipase A2, group IVA (cytosolic, calcium-dependent)	Mus musculus	39-44	
34428833-5	2021	These inhibitory effects of THC were partially mediated by the attenuation of cytosolic phospholipase A2 (cPLA2) phosphorylation, leading to a decrease in thromboxane A2 (TxA2) generation.	tetrahydrocurcumin	28-31	phospholipase A2, group IVA (cytosolic, calcium-dependent)	Mus musculus	78-104	
34428833-5	2021	These inhibitory effects of THC were partially mediated by the attenuation of cytosolic phospholipase A2 (cPLA2) phosphorylation, leading to a decrease in thromboxane A2 (TxA2) generation.	tetrahydrocurcumin	28-31	phospholipase A2, group IVA (cytosolic, calcium-dependent)	Mus musculus	106-111	
34428833-6	2021	Moreover, the MAPK (Erk1/2, JNK1/2, and p38 MAPK) signaling pathways were downregulated by THC treatment, resulting in reduced cPLA2 activation, TxA2 generation, and granule secretion.	tetrahydrocurcumin	91-94	phospholipase A2, group IVA (cytosolic, calcium-dependent)	Mus musculus	127-132	
34428833-10	2021	Thus, through inhibiting MAPKs/cPLA2 signaling, and attenuating platelet TxA2 generation, granule secretion, and thrombus formation, THC may be a potent cardioprotective agent.	tetrahydrocurcumin	133-136	phospholipase A2, group IVA (cytosolic, calcium-dependent)	Mus musculus	31-36